+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Transfusion Diagnostics Market by Product, Technology, End User, Application - Global Forecast to 2030- Product Image
Blood Transfusion Diagnostics Market by Product, Technology, End User, Application - Global Forecast to 2030- Product Image
Sale

Blood Transfusion Diagnostics Market by Product, Technology, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010986
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The blood transfusion diagnostics market is rapidly evolving as healthcare systems demand greater accuracy and safety in blood screening and compatibility testing. Senior decision-makers face a landscape shaped by technological advancement, increasing regulatory scrutiny, complex supply chains, and shifting clinical priorities.

Market Snapshot: Blood Transfusion Diagnostics Market

The Blood Transfusion Diagnostics Market grew from USD 3.86 billion in 2024 to USD 4.25 billion in 2025. It is expected to continue growing at a CAGR of 9.83%, reaching USD 6.77 billion by 2030. These figures underscore robust expansion driven by clinical innovation, regulatory mandates, and a heightened focus on transfusion safety at both provider and policy levels.

Scope & Segmentation

This report offers a strategic breakdown of the blood transfusion diagnostics market, ensuring clarity across products, technologies, end users, applications, regions, and top companies.

  • Product Lines: Consumables and accessories, including microplates and pipette tips; instruments such as NAT analyzers, pathogen reduction systems, and serology analyzers; reagents and kits comprising amplification reagents (isothermal and real-time PCR mixes), antibody reagents (monoclonal and polyclonal), and DNA extraction kits (magnetic bead based and spin column).
  • Technology Platforms: Nucleic acid testing (standard PCR, real-time PCR, transcription mediated amplification); pathogen reduction technology (amotosalen, methylene blue, riboflavin); and serological testing (CLIA, ELISA, lateral flow assays).
  • End Users: Hospital blood banks, independent laboratories, research institutes.
  • Applications: Donation screening, immunohematology and viral marker screening, quality control (external proficiency and internal QC), transfusion safety (blood group typing, pathogen inactivation).
  • Regions Covered: Americas (focus on United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (key countries such as United Kingdom, Germany, France, Italy, and emerging markets), and Asia-Pacific (notably China, India, Japan, Australia, South Korea, and Southeast Asia).
  • Leading Companies Profiled: Ortho Clinical Diagnostics, Grifols, Thermo Fisher Scientific, Immucor, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Abbott, Siemens Healthineers, bioMérieux.

Key Takeaways for Senior Decision-Makers

  • Advanced molecular diagnostics and pathogen reduction systems are raising safety and reliability benchmarks in blood transfusion diagnostics.
  • Automation and digital connectivity are streamlining testing workflows, supporting faster decision-making and minimizing operational errors in both central and decentralized settings.
  • Strategic partnerships across manufacturers, biotech firms, and service providers are driving the development of integrated, scalable platforms tailored to diverse healthcare environments.
  • Regional diversity demands adaptive go-to-market strategies, as healthcare infrastructure, regulatory frameworks, and procurement preferences vary significantly between the Americas, EMEA, and Asia-Pacific.
  • Product segmentation reveals recurring revenue streams from consumables and opportunities for differentiation in high-value instrument and kit offerings.

Tariff Impact: Navigating U.S. Trade Pressures

Forthcoming U.S. tariffs on imported consumables, reagents, and instrumentation components are increasing operational costs. Market players are responding by optimizing supply chains through domestic sourcing, consortium purchasing, and regional manufacturing. This disruption is stimulating investment in automation, greater supply chain resilience, and volume purchasing to contain costs. Sector leaders are carefully evaluating nearshoring and alternative procurement models to mitigate ongoing volatility.

Methodology & Data Sources

Analysis draws on primary interviews with sector experts, laboratory managers, and industry executives, combined with secondary research from scientific publications, regulatory filings, financial records, and industry conferences. Triangulation of these datasets ensures a well-rounded perspective on trends and market shifts in blood transfusion diagnostics.

Why This Report Matters

  • Provides actionable intelligence to support procurement, investment, and R&D decisions within the blood transfusion diagnostics sector.
  • Enables cross-functional teams to identify emerging risks and high-value opportunities segment by segment and region by region for more effective business planning.

Conclusion

This report supports leaders in navigating rapid market changes, shifting trade policies, and emerging technology standards. Forward-looking strategies informed by this analysis can strengthen competitive positioning and enhance the safety and efficiency of transfusion services worldwide.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Transfusion Diagnostics Market, by Product
8.1. Introduction
8.2. Consumables & Accessories
8.2.1. Microplates
8.2.2. Pipette Tips
8.3. Instruments
8.3.1. Nat Analyzers
8.3.2. Pathogen Reduction Systems
8.3.3. Serology Analyzers
8.4. Reagents & Kits
8.4.1. Amplification Reagents
8.4.1.1. Isothermal Amplification Reagents
8.4.1.2. Real Time Pcr Mix
8.4.2. Antibody Reagents
8.4.2.1. Monoclonal Antibodies
8.4.2.2. Polyclonal Antibodies
8.4.3. Dna Extraction Kits
8.4.3.1. Magnetic Bead Based Kits
8.4.3.2. Spin Column Kits
9. Blood Transfusion Diagnostics Market, by Technology
9.1. Introduction
9.2. Nucleic Acid Testing
9.2.1. Pcr
9.2.2. Real Time Pcr
9.2.3. Transcription Mediated Amplification
9.3. Pathogen Reduction Technology
9.3.1. Amotosalen
9.3.2. Methylene Blue
9.3.3. Riboflavin
9.4. Serological Testing
9.4.1. Clia
9.4.2. Elisa
9.4.3. Lateral Flow Assays
10. Blood Transfusion Diagnostics Market, by End User
10.1. Introduction
10.2. Hospital Blood Banks
10.3. Independent Laboratories
10.4. Research Institutes
11. Blood Transfusion Diagnostics Market, by Application
11.1. Introduction
11.2. Donation Screening
11.2.1. Immunohematology Testing
11.2.2. Viral Marker Screening
11.3. Quality Control
11.3.1. External Proficiency Testing
11.3.2. Internal Quality Control
11.4. Transfusion Safety
11.4.1. Blood Group Typing
11.4.2. Pathogen Inactivation
12. Americas Blood Transfusion Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Blood Transfusion Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Blood Transfusion Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Ortho Clinical Diagnostics, Inc.
15.3.2. Grifols, S.A.
15.3.3. Thermo Fisher Scientific Inc.
15.3.4. Immucor, Inc.
15.3.5. Bio-Rad Laboratories, Inc.
15.3.6. Danaher Corporation
15.3.7. F. Hoffmann-La Roche Ltd
15.3.8. Abbott Laboratories
15.3.9. Siemens Healthineers AG
15.3.10. bioMérieux SA
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BLOOD TRANSFUSION DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. BLOOD TRANSFUSION DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD TRANSFUSION DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BLOOD TRANSFUSION DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BLOOD TRANSFUSION DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD TRANSFUSION DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PIPETTE TIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NAT ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR MIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY MAGNETIC BEAD BASED KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SPIN COLUMN KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMOTOSALEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY METHYLENE BLUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY RIBOFLAVIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CLIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY HOSPITAL BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY IMMUNOHEMATOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY VIRAL MARKER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY EXTERNAL PROFICIENCY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INTERNAL QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY BLOOD GROUP TYPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN INACTIVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 97. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 99. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 100. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 101. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 102. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 103. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 104. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2030 (USD MILLION)
TABLE 106. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2030 (USD MILLION)
TABLE 108. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2030 (USD MILLION)
TABLE 111. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2030 (USD MILLION)
TABLE 112. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2030 (USD MILLION)
TABLE 113. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 115. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 116. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 119. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2030 (USD MILLION)
TABLE 122. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2030 (USD MILLION)
TABLE 124. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2030 (USD MILLION)
TABLE 127. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2030 (USD MILLION)
TABLE 128. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2030 (USD MILLION)
TABLE 194. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 196. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 197. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 198. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 199. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 200. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 201. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2030 (USD MILLION)
TABLE 203. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2030 (USD MILLION)
TABLE 205. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2030 (USD MILLION)
TABLE 208. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2030 (USD MILLION)
TABLE 209. GERMANY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2030 (USD MILLION)
TABLE 210. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 212. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 213. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 214. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 215. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 216. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 217. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2030 (USD MILLION)
TABLE 219. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2030 (USD MILLION)
TABLE 221. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2030 (USD MILLION)
TABLE 224. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2030 (USD MILLION)
TABLE 225. FRANCE BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2030 (USD MILLION)
TABLE 242. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 244. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 245. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 246. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 247. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 248. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 249. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2030 (USD MILLION)
TABLE 251. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2030 (USD MILLION)
TABLE 253. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2030 (USD MILLION)
TABLE 256. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2030 (USD MILLION)
TABLE 257. ITALY BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2030 (USD MILLION)
TABLE 258. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 260. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 261. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 262. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 263. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 264. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 265. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2030 (USD MILLION)
TABLE 267. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2030 (USD MILLION)
TABLE 269. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2030 (USD MILLION)
TABLE 272. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2030 (USD MILLION)
TABLE 273. SPAIN BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2030 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2030 (USD MILLION)
TABLE 290. SAUDI ARABIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 292. SAUDI ARABIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 294. SAUDI ARABIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, 2018-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, 2018-2030 (USD MILLION)
TABLE 296. SAUDI ARABIA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, 2018-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Blood Transfusion Diagnostics market report include:
  • Ortho Clinical Diagnostics, Inc.
  • Grifols, S.A.
  • Thermo Fisher Scientific Inc.
  • Immucor, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • bioMérieux SA

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.25 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.77 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Blood Transfusion Diagnostics - Global Strategic Business Report - Product Image

Blood Transfusion Diagnostics - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Blood Transfusion Diagnostics Market Report 2025 - Product Image

Blood Transfusion Diagnostics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Blood Transfusion Diagnostics Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Blood Transfusion Diagnostics Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 158 Pages
  • Global
From
Blood Transfusion Diagnostics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Blood Transfusion Diagnostics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 97 Pages
  • Global
From
Blood Transfusion Devices Market by Product, Application, End User, Component, Mode, Distribution Channel, Technology - Global Forecast to 2030 - Product Image

Blood Transfusion Devices Market by Product, Application, End User, Component, Mode, Distribution Channel, Technology - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From

About the Transfusion Diagnostics Market

The Transfusion Diagnostics market is a segment of the In Vitro Diagnostics (IVD) industry. It focuses on the development and production of diagnostic tests used to detect and monitor blood-borne diseases, such as HIV, hepatitis, and syphilis. These tests are used to ensure the safety of blood transfusions and to monitor the health of blood donors. Transfusion Diagnostics tests are used in hospitals, blood banks, and other healthcare settings. The Transfusion Diagnostics market is driven by the increasing demand for safe and reliable blood transfusions, as well as the need for improved patient safety. Additionally, the development of new technologies, such as molecular diagnostics, has enabled the development of more accurate and sensitive tests. Some companies in the Transfusion Diagnostics market include Abbott, Bio-Rad Laboratories, Becton Dickinson, Ortho Clinical Diagnostics, and Siemens Healthineers. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.